Our research focuses on developing genome editing as curative therapy for genetic diseases. Our lab is particularly interested in applying genome editing for gene therapy of hematopoietic genetic disorders such as severe combined immunodeficiency (SCID). Additional aspect of our research focuses on applying the CRISPR technology to treat malignancies using cancer-immunotherapy.